Antibody response and risk of reinfection over two years among the first wave of COVID-19 patients
Description
CONCLUSIONS: First wave patients had durable natural humoral immunity in 40% and anti-S-RBD response in 100% up to two years after infection. Natural humoral response alone was not protective against reinfections with omicron SARS-CoV-2 variants
